© 2020 MJH Life Sciences and Contagion Live. All rights reserved.
© 2020 MJH Life Sciences™ and Contagion Live. All rights reserved.
October 27, 2020
These vital cells that are recovered from COVID-19 patients might be able to help people with compromised immune systems due to cancer therapy or transplantation.
While they decided to discontinue this trial in hospitalized COVID-19 patients, Lilly is continuing their other trials with the medication for COVID-19 treatment.
October 26, 2020
Invasive C glabrata found to be most prevalent strain of Candida in stool of patients with C difficile infection, and likely resistant to caspofungin.
A glimpse into FDA advisor perspective just weeks before EUAs are anticipated to be sent.
The company is planning to move forward after receiving a recommendation from the DSMB to start up the trial again.